Responding to the opioid and overdose crisis with innovative services: The recovery community center office-based opioid treatment (RCC-OBOT) model

Addict Behav. 2019 Nov:98:106031. doi: 10.1016/j.addbeh.2019.106031. Epub 2019 Jun 21.

Abstract

Opioid use disorder (OUD) and opioid-related overdose mortality are major public health concerns in the United States. Recently, several community-based and professional innovations - including hybrid recovery community organizations, peer-based emergency department warm handoff programs, emergency department buprenorphine induction, and low-threshold OUD treatment programs - have emerged or expanded in an effort to address significant obstacles to providing patients the care needed for OUD and to reduce the risk of overdose. Additional innovations are needed to address the crisis. Building upon the foundational frameworks of each of these recent innovations, a new model of OUD pharmacotherapy is proposed and discussed: the Recovery Community Center Office-Based Opioid Treatment model. Additionally, two potential implementation scenarios, the overdose and non-overdose event protocols, are detailed for communities, peers, and practitioners interested in implementing the model. Potential barriers to implementation of the model include service reimbursement, licensing regulations, and organizational concerns. Future research should seek to validate the model and to identify actual implementation and sustainability barriers and best practices.

Keywords: Low threshold; Office-based opioid treatment; Opioid use disorder; Overdose; Peer services; Recovery community organizations.

Publication types

  • Review

MeSH terms

  • Buprenorphine / therapeutic use
  • Community Health Centers*
  • Drug Overdose / drug therapy*
  • Emergency Service, Hospital
  • Humans
  • Narcotic Antagonists / therapeutic use
  • Opiate Substitution Treatment / methods*
  • Opioid-Related Disorders / drug therapy*
  • Referral and Consultation
  • United States

Substances

  • Narcotic Antagonists
  • Buprenorphine